Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Webinar Co-Hosted with Bioanalysis Zone
Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant? BioAgilytix’s Global CSO, Dr. Arno Kromminga addresses this subject and more.
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
1 Day Agoview on linkedin
While our reach is global, our customer relationships are personal. Reach out to one of our scientists today to learn how we can help to support even the most complicated large molecule studies. https://lnkd.in/gX9rnxR
1 Day Agoview on linkedin
Support one of the most expert & innovative scientific teams in the industry as a Study Coordinator for BioAgilytix. In this role, you will manage many parts of the project lifecycle collaboratively with our Durham, NC team. Apply today: https://lnkd.in/eE3m7yH
2 Days Agoview on linkedin
While some immune cells cause the damaging brain inflammation of multiple sclerosis, others work to mitigate it. Researchers have discovered that some white blood cells produced in the gut can dampen brain inflammation in MS, which could lead to new therapeutic approaches. Read more via FierceBiotech: https://lnkd.in/e8eV9dX
January 17, 2019BioAgilytix Team Q&A: Meet Gabi Schewe, Lab Manager at BioAgilytix Europe
January 8, 2019Ligand-Binding Assay Optimization, Part 1: Critical Attributes of Platforms Used
December 20, 2018BioAgilytix Announces Several Promotions within Its Leadership Team
November 2, 2018BioAgilytix to be Acquired by Private Investment Company Cobepa
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.
